Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use? - Wikidata - wikimedia - TriplyDB

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

http://www.wikidata.org/entity/Q36707530

about

Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.

P2860

Q26768162-FFB779B7-9DE9-4A0B-9CAE-1E90FD24150D Q38988477-40AAE16A-74B0-48F8-9253-7B379CA0D959 Q39134052-D2FCA2B5-662A-4E6A-ACA2-3FEE64A97881

P2860

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

http://www.wikidata.org/entity/Q36707530

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@ast

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@en

type

label

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@ast

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@en

prefLabel

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@ast

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@en

P1433

Q36707530-0A939C44-0D1F-4356-BB74-71E13AA08F3D

P1476

Q36707530-1148A3CB-1F56-4C19-B2DA-F0EAEBAE663A

P2093

Q36707530-2C33DD66-3AFB-4ADB-AA03-DA399C68F02B

Q36707530-BC0D9F01-3A12-4F48-84C7-5FA7A6C73E6C

P2860

Q36707530-0D5A283A-4331-4D2A-8B9C-54827DD52DB3

Q36707530-0DE5C25A-2146-4A13-B5F3-2F6672745453

Q36707530-0E18C7B9-C5F7-4427-A9DA-7A32B271891C

Q36707530-0E55B0D1-3DB8-4B34-A949-8821441A8858

Q36707530-107211D7-B4B3-418F-8008-3C80B210CECC

Q36707530-10CBBCDB-5D03-4C7B-AE9E-D676F4E34433

Q36707530-15691C6C-CDF2-49EE-A945-1BCE8744C22E

Q36707530-20CEA130-AE0A-4134-9F61-69298329AD60

Q36707530-21D046C2-E759-4EFE-B62E-AC4EF113CF1E

Q36707530-28D0DD26-CA4E-4F4F-8DC3-3BA6F5CDBC5F

P304

Q36707530-A311EB20-F660-4735-B4B8-5D9DC560F036

P31

Q36707530-EAA6B4DB-57E2-41AB-A425-583F4F50A478

P356

Q36707530-24AEF6A7-9C18-479D-A10F-F9CB89D7F6EA

P433

Q36707530-FD1F8080-00A4-4B4A-9502-7A04C8624B4F

P478

Q36707530-32DB2863-D9D3-47DF-9D14-7C8BE518AB90

P577

Q36707530-54C6681C-4DF1-4F9C-8D95-4B9CA791AA02

P698

Q36707530-6BA3EB00-15B9-47E4-869A-30B886F483A7

P932

Q36707530-AE395025-7B04-48C9-B0F6-F34900A6E013

P356

J.JASH.2013.01.004

P1433

Journal of the American Society of Hypertension

P1476

Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

@en

P2093

Alejandro R Chade

http://www.w3.org/2001/XMLSchema#string

Nicholas Stewart

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of FGF and BMP family proteins and VEGF in early human kidney development

VEGF inhibition and renal thrombotic microangiopathy

The biology of VEGF and its receptors

Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli

Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle

Role of platelet-derived growth factors in physiology and medicine

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.

P304

180-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JASH.2013.01.004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23428409

http://www.w3.org/2001/XMLSchema#string

P932

3605220

http://www.w3.org/2001/XMLSchema#string